PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Company Stats
- Market Cap
- $736.7M
- as of Sep 30, 2026
- Shares Outstanding
- 310.8M
- Free Float
- 88.0%
Income Statement
- Revenue
- $160.0M
- Operating Income
- -$553.9M
- Net Income
- -$546.4M
- EBITDA
- -$540.9M
- Revenue Growth, 3Y
- 7.6%
- FCF Margin, 3Y Avg
- -114.2%
- FCF Margin, Worst Year
- -137.8%
Cash Flow
- Free Cash Flow
- -$113.9M
- FCF Yield
- -15.5%
- Owner FCF Yield
- -21.1%
Balance Sheet
- Cash & Equivalents
- $63.7M
Returns & Capital
- SBC, 3Y Avg
- $61.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $160.0M | -$113.9M | -71.2% |
| FY2024 | $154.0M | -$212.2M | -137.8% |
| FY2023 | $200.5M | -$268.0M | -133.7% |
| FY2022 | $128.3M | -$280.0M | -218.2% |
| FY2021 | $130.5M | -$117.1M | -89.7% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back